| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920127 | Radiotherapy and Oncology | 2005 | 4 Pages |
Abstract
Aim of the present study was to test, activity and toxicity of a rapidly alternating chemoradiation (paclitaxel based) in 31 patients with unresectable, locally advanced or recurrent after surgery, head and neck cancer. Three-year overall survival and progression-free survival were 61.4 and 73.7%, respectively. Main side effects remain a major problem.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marco Merlano, Elvio G. Russi, Gianmauro Numico, Ida Colantonio, Ornella Garrone, Antonio Pelissero, Cristina Granetto, Milena Gasco, Gianna Di Costanzo, Abdelhamid Heouaine, Riccardo Vigna Taglianti, Marco Cipolat,